Market Cap 1.94B
Revenue (ttm) 150,000.00
Net Income (ttm) -59.35M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -39,566.66%
Debt to Equity Ratio 0.00
Volume 14,600
Avg Vol N/A
Day's Range N/A - N/A
Shares Out 105.00M
Stochastic %K N/A
Beta N/A
Analysts Sell
Price Target $19.12
thenewmoney
thenewmoney Oct. 1 at 4:01 PM
There’s a select group of public companies who have exceeded a market capitalization of a trillion dollars or more. And now, they have their very own ETF. $TRIL https://share.thenew.money/article/theres-a-new-etf-on-wall-street-for-trillion-dollar-companies-and-assets
0 · Reply
ValueHawk23
ValueHawk23 Sep. 17 at 12:50 PM
0 · Reply
Smittysixty
Smittysixty Sep. 2 at 7:38 PM
$PPBT The Biotech Playbook in Motion Volume spikes. Price suppression. Troll surge. Seen it before: $IMMU, $ARNA, $TRIL. Same setup. Same silence. Same endgame. Retail’s not rattled. Shorts are.
0 · Reply
WAYWARD_SUN
WAYWARD_SUN Aug. 14 at 7:00 PM
0 · Reply
Thomasdickinson337
Thomasdickinson337 Aug. 10 at 2:36 AM
$XFOR This could end up like $TRIL back in 2019....trading at $.25....nobody wanted it....2 years later they get bought out for $18.50 by $PFE. Traded as high as $20....its dogshit till its not. Pre-R/S price is $6.66, currently sitting at $8M MC
0 · Reply
volality
volality May. 24 at 7:39 PM
$IMNN Historical data from a drug stock $TRIL a few years back. They did a private placement before the BO This could be similar. JMO
1 · Reply
WAYWARD_SUN
WAYWARD_SUN May. 23 at 10:33 PM
2 · Reply
Whtmtn
Whtmtn May. 8 at 2:01 PM
$ADAP Some interesting tidbits from the 10K that I just got around to reading: The risk factors are longer than a Charlie Manson rap sheet, there are now 266M shares outstanding (I believe from ~8M options granted in Q1'25 with 4M at the market strike and 4M at nominal or .01 strike), ~3.1M ADR equivalent options were forfeited or expired with avg exercise price of $3.00, 1.5M ADRs were exercised with avg exercise price of $0.05 and the 33% reduction in headcount Adrian advertised turned out to be 29%. There are 42M outstanding options with an avg ex price of $1.86, which means it's likely many will expire. The company received $77K for the exercised options in 2024, thank you employees such a sacrifice!! Sort of frames up where valuations might fall. This ain't no $TRIL.
0 · Reply
financialsarthis
financialsarthis Apr. 24 at 11:10 AM
Transformers, Power Giants & FIIs: Q4 Ownership Trends That May Surprise You! 🧵 Who’s Buying? Who’s Booking? 📊 Tracking FII, DII & Public shareholding shifts (Q4 vs Q3) in Power & Transformers👇 A Mega Thread🧵 $TRIL – Transformers & Rectifiers (India) Ltd 📈 FII: 11.08% → 11.33% 📉 DII: 7.68% → 7.22% 📈 Public: 16.88% → 17.07% $SIEMENS – Siemens Ltd 📉 FII: 8.77% → 8.19% 📈 DII: 6.78% → 7.29% 📈 Public: 9.45% → 9.51% $INDOTECH – Indo Tech Transformers 📉 FII: 0.48% → 0.24% ➖ DII: 0.66% → 0.66% 📈 Public: 23.85% → 24.08% $VOLTAMP – Voltamp Transformers 📉 FII: 26.70% → 23.91% 📉 DII: 23.70% → 23.53% 🚀 Public: 11.51% → 14.48% $CGPOWER – CG Power & Industrial Solutions 📉 FII: 14.30% → 12.97% 📈 DII: 11.91% → 13.58% 📉 Public: 15.73% → 15.39% $APARINDS – Apar Industries 📉 FII: 10.22% → 9.87% 📉 DII: 21.24% → 20.63% 📈 Public: 10.77% → 11.73% $BHARATBIJLEE – Bharat Bijlee 📉 FII: 5.30% → 3.79% 📉 DII: 17.77% → 17.34% 📈 Public: 43.26% → 45.19% $BHEL – Bharat Heavy Electricals Ltd 📉 FII: 7.98% → 7.19% 📈 DII: 15.49% → 16.34% 📉 Public: 13.36% → 13.29% $SHILCHAR – Shilchar Technologies 📉 FII: 2.29% → 2.05% ➖ DII: 0.11% → 0.11% 📈 Public: 33.06% → 33.30%
0 · Reply
EddieH2020
EddieH2020 Apr. 23 at 6:18 PM
$SLS Look up $TRIL buyout history next 👍
0 · Reply
Latest News on TRIL
No data available.
thenewmoney
thenewmoney Oct. 1 at 4:01 PM
There’s a select group of public companies who have exceeded a market capitalization of a trillion dollars or more. And now, they have their very own ETF. $TRIL https://share.thenew.money/article/theres-a-new-etf-on-wall-street-for-trillion-dollar-companies-and-assets
0 · Reply
ValueHawk23
ValueHawk23 Sep. 17 at 12:50 PM
0 · Reply
Smittysixty
Smittysixty Sep. 2 at 7:38 PM
$PPBT The Biotech Playbook in Motion Volume spikes. Price suppression. Troll surge. Seen it before: $IMMU, $ARNA, $TRIL. Same setup. Same silence. Same endgame. Retail’s not rattled. Shorts are.
0 · Reply
WAYWARD_SUN
WAYWARD_SUN Aug. 14 at 7:00 PM
0 · Reply
Thomasdickinson337
Thomasdickinson337 Aug. 10 at 2:36 AM
$XFOR This could end up like $TRIL back in 2019....trading at $.25....nobody wanted it....2 years later they get bought out for $18.50 by $PFE. Traded as high as $20....its dogshit till its not. Pre-R/S price is $6.66, currently sitting at $8M MC
0 · Reply
volality
volality May. 24 at 7:39 PM
$IMNN Historical data from a drug stock $TRIL a few years back. They did a private placement before the BO This could be similar. JMO
1 · Reply
WAYWARD_SUN
WAYWARD_SUN May. 23 at 10:33 PM
2 · Reply
Whtmtn
Whtmtn May. 8 at 2:01 PM
$ADAP Some interesting tidbits from the 10K that I just got around to reading: The risk factors are longer than a Charlie Manson rap sheet, there are now 266M shares outstanding (I believe from ~8M options granted in Q1'25 with 4M at the market strike and 4M at nominal or .01 strike), ~3.1M ADR equivalent options were forfeited or expired with avg exercise price of $3.00, 1.5M ADRs were exercised with avg exercise price of $0.05 and the 33% reduction in headcount Adrian advertised turned out to be 29%. There are 42M outstanding options with an avg ex price of $1.86, which means it's likely many will expire. The company received $77K for the exercised options in 2024, thank you employees such a sacrifice!! Sort of frames up where valuations might fall. This ain't no $TRIL.
0 · Reply
financialsarthis
financialsarthis Apr. 24 at 11:10 AM
Transformers, Power Giants & FIIs: Q4 Ownership Trends That May Surprise You! 🧵 Who’s Buying? Who’s Booking? 📊 Tracking FII, DII & Public shareholding shifts (Q4 vs Q3) in Power & Transformers👇 A Mega Thread🧵 $TRIL – Transformers & Rectifiers (India) Ltd 📈 FII: 11.08% → 11.33% 📉 DII: 7.68% → 7.22% 📈 Public: 16.88% → 17.07% $SIEMENS – Siemens Ltd 📉 FII: 8.77% → 8.19% 📈 DII: 6.78% → 7.29% 📈 Public: 9.45% → 9.51% $INDOTECH – Indo Tech Transformers 📉 FII: 0.48% → 0.24% ➖ DII: 0.66% → 0.66% 📈 Public: 23.85% → 24.08% $VOLTAMP – Voltamp Transformers 📉 FII: 26.70% → 23.91% 📉 DII: 23.70% → 23.53% 🚀 Public: 11.51% → 14.48% $CGPOWER – CG Power & Industrial Solutions 📉 FII: 14.30% → 12.97% 📈 DII: 11.91% → 13.58% 📉 Public: 15.73% → 15.39% $APARINDS – Apar Industries 📉 FII: 10.22% → 9.87% 📉 DII: 21.24% → 20.63% 📈 Public: 10.77% → 11.73% $BHARATBIJLEE – Bharat Bijlee 📉 FII: 5.30% → 3.79% 📉 DII: 17.77% → 17.34% 📈 Public: 43.26% → 45.19% $BHEL – Bharat Heavy Electricals Ltd 📉 FII: 7.98% → 7.19% 📈 DII: 15.49% → 16.34% 📉 Public: 13.36% → 13.29% $SHILCHAR – Shilchar Technologies 📉 FII: 2.29% → 2.05% ➖ DII: 0.11% → 0.11% 📈 Public: 33.06% → 33.30%
0 · Reply
EddieH2020
EddieH2020 Apr. 23 at 6:18 PM
$SLS Look up $TRIL buyout history next 👍
0 · Reply
pkbull
pkbull Mar. 12 at 5:35 PM
@Soll2019 hey man, where have you been? It’s been a while since you have posted anything . I hope you’re doing well. I remember you from $TRIL
0 · Reply
look2theblue
look2theblue Feb. 7 at 1:43 PM
$ITRM Yep, we've got multiple parties interested in acquiring Iterum and they are simply playing hard to get to drive the acquisition price higher. Same thing happened with $TRIL Trillium Therapeutics which $PFE ultimately end up buying after upping their offer. They are trying to "maximize share holder value" - i.e. get them to bid higher.
1 · Reply
BiotechValues
BiotechValues Jan. 30 at 2:50 PM
$BCAB contrarian play, but I think this can recover big in 2025. I've been buying back heavily in the $0.40s ($27M market cap). Reminds me of $TRIL years back before the huge run up. New slide deck says partnering in progress on ROR2 and CTLA4. $9M raise in Dec was likely bridge
2 · Reply
mikeyv6969
mikeyv6969 Jan. 24 at 1:09 AM
$ABUS One day we will look back and this will be a $TRIL type of move. Yes it’s taking ages, yes it’s annoying, but we have many good things coming. Be patient; if you truly believe buy more. Our day will come
1 · Reply
Vavavoom
Vavavoom Jan. 17 at 2:16 PM
$CRDF onva is a new class just as $TRIL ‘s molecules were . $ tril’s molecules already had competition from gilead’s takeover of a co with similar class of drugs . Onva for rx of a solid tumor which can happen in younger ppl - a better regimen should give them a fighting chance . $TRIL dropped from around $12 ( after good news in April 21 ) to almost $5 in sept before acquisition at $18.5 So who said MMs don’t play games ?
1 · Reply
TwitWalt
TwitWalt Jan. 2 at 5:58 PM
$QNCCF This could be signs of a merger. They beat the stock up to buy more ahead of the official meger. This happened to $TRIL before it was bought out by Pfizer. I never sold thru constant halts from like $1.00 to 23.00 before it was bought out.. Never any reason for the halts either. But who knows. I sure don't
0 · Reply
look2theblue
look2theblue Nov. 15 at 8:34 PM
$BLUE Oh the stories on $TRIL are fascinating. Given $PFE stock price today, they'd be wise to do a deal with $BLUE particularly since the Trump administration has voiced support for Sickle Cell Disease cures. Would be a good way to stay in their good graces with RFK making noise about vaccines. Wouldn't want to own $MRNA today.
0 · Reply
look2theblue
look2theblue Nov. 15 at 6:42 PM
$BLUE The $TRIL story was one for the ages. Could that happen here, sure. It was a fun ride.
1 · Reply
Xmarketsthestock
Xmarketsthestock Nov. 15 at 6:50 AM
0 · Reply
BloodyPortfolio
BloodyPortfolio Aug. 19 at 7:32 PM
$VKTX No Fade for the shorts! It's happening here - $TRIL $IMGN.
0 · Reply
FE123
FE123 Aug. 13 at 7:19 AM
$SGMO Never forget that Move $TRIL made from about .50 to $20! Could $SGMO be Next?
2 · Reply
FE123
FE123 Aug. 12 at 7:28 PM
$SGMO The next $TRIL ?
0 · Reply